July 2026– date –
-
ACS Publications Unveils Multimodal Cell-Free Biosensing Platform for Highly Sensitive Detection of Lethal Mushroom Toxin α-Amanitin
ACS Publications USA Overview This research developed a transcription-based multimodal cell-free biosensing platform for highly sensitive detection of α-amanitin, a lethal mushroom toxin. The platform converts α-amanitin-dependent RNA po... -
Smartwatches Revolutionize Blood Sugar Management: Dexcom G7 and FreeStyle Libre Enhance Apple Watch Integration, Expanding AI-Driven Ecosystem
TechRepublic USA Overview Smartwatches hold the potential to transform glucose tracking, but current advancements rely on the integration of continuous glucose monitoring (CGM), artificial intelligence (AI), and regulated healthcare tech... -
China’s POMDOCTOR Pivots to AI-Driven Predictive Healthcare Platform, Integrating Wearables & Data for Enhanced Chronic Disease Management
Stock Titan China Overview China-based digital healthcare company POMDOCTOR announced a strategic pivot to an AI-driven predictive healthcare platform. The company plans to integrate wearable devices, artificial intelligence, physician r... -
July 2026 Digital Health Trends: AI Wearable Patch Hits 99.6% Arrhythmia Detection, Clair Health Secures $11.6M for Women’s Health Wearable
Digital Health Trends (Openloop Health blog) USA Overview June 2026 marked significant advancements in digital health. An AI wearable patch achieved 99.6% accuracy in detecting life-threatening arrhythmias, while Midjourney unveiled an u... -
RSC Publishing: Machine Learning-Augmented Lateral Flow Assays Dramatically Boost Sensitivity & Quantification in Infectious Disease POCT Diagnostics
Lab on a Chip (RSC Publishing) UK Overview Lateral Flow Assays (LFAs) are widely used as Point-of-Care (PoC) diagnostic platforms for infectious diseases due to their rapid operation, low cost, and user-friendly design. However, conventi... -
MEDICA Highlights POCT’s Critical Role in Emergency Departments: Rapid Diagnostics Enhance Clinical Decision-Making in Time-Sensitive Situations
MEDICA Germany Overview MEDICA emphasized that Point-of-Care Testing (POCT) in emergency departments significantly supports clinical decision-making in time-constrained situations by providing rapid diagnostic data. POCT delivers critica... -
Continuous Lactate Monitoring: The Next Breakthrough After CGM, Driven by Wearable Sensors and AI
After CGM (Diabetes in Control) USA Overview While Continuous Glucose Monitoring (CGM) revolutionized diabetes management, Continuous Lactate Monitoring (CLM) is now discussed as the next significant advance in metabolic monitoring. Lact... -
MDPI: Nanomaterial & AI-Enhanced Biosensors Modernize Asthma Diagnostics, Enabling Low-Concentration Detection of Salivary IL-8 and Other Biomarkers
MDPI Switzerland Overview Biosensors enhanced by nanomaterials and artificial intelligence are driving the modernization of asthma diagnostics. Optical biosensors are gaining popularity due to their real-time, label-free detection capabi... -
GoodRx Compares Leading CGMs: Dexcom G7 10-Day Sensor Emerges as Sole FDA-Approved Device for Children Ages 2+
GoodRx USA Overview According to a GoodRx comparison report, the Dexcom G7 10-day sensor is FDA-approved for adults and children aged 2 and older, while the Dexcom G7 15-day sensor and Eversense 365 are approved exclusively for adults ag... -
AI, Digital Health, & Remote Monitoring Revolutionize Obesity Care: Real-time Intervention via Wearables & Mobile Apps
AI in Digital Health & Remote Monitoring India Overview Artificial Intelligence (AI), digital health platforms, and remote patient monitoring systems are rapidly transforming the healthcare industry's approach to obesity and metabolic di...
